NSCLC: Role of ADCs and Ongoing EVOKE-01 and EVOKE-03 Studies

Opinion
Video

Medical oncologists discuss where antibody-drug conjugates fit in the overall non–small cell lung cancer treatment landscape and review the ongoing EVOKE-01 and EVOKE-03 clinical trials.

Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Presented by the Onc Brothers
Presented by the Onc Brothers
Presented by the Onc Brothers
Presented by the Onc Brothers
Solly Chedid, MD, and Jamie Koprivnikar, MD
Related Content